The company had a net profit of Rs 44.61 crore for the same period in the previous fiscal, JB Chemicals & Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
As the company sold its Russia-CIS OTC business to Cilag GmbH International, a subsidiary of US-based Johnson and Johnson for Rs 754.53 crore, the results of the current quarter are not comparable with the same period previous fiscal.
370
433
249
279
801
890
210
299
288
399